9,10-dimethyl-1,2-benzanthracene has been researched along with onapristone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebert, K; Knuppen, R; Michna, H; Vollmer, G | 1 |
| el Etreby, MF; Michna, H; Nishino, Y; Schneider, MR | 2 |
| Deckers, GH; Kloosterboer, HJ; Schoonen, WG | 1 |
| Michna, H; Nishino, Y; Schneider, MR | 1 |
| Hirtreiter, C; Ishibashi, K; Nishino, T; Nishino, Y | 1 |
6 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and onapristone
| Article | Year |
|---|---|
Down-regulation of tenascin expression by antiprogestins during terminal differentiation of rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Adhesion Molecules, Neuronal; Cell Differentiation; Extracellular Matrix Proteins; Female; Gonanes; Immunohistochemistry; Mammary Neoplasms, Experimental; Methylnitrosourea; Ovariectomy; Progesterone; Rats; Tamoxifen; Tenascin; Uterus | 1992 |
Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Estrenes; Female; Gonanes; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mifepristone; Neoplasms, Hormone-Dependent; Progesterone; Rats; Rats, Inbred Strains | 1989 |
Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Gonanes; Mammary Neoplasms, Experimental; Methylnitrosourea; Mifepristone; Neoplasm Transplantation; Organ Size; Ovariectomy; Ovary; Rats; Rats, Inbred Strains; Uterus; Vagina | 1989 |
Pharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Abortifacient Agents, Steroidal; Abortion, Induced; Androgen Antagonists; Animals; Estrenes; Female; Furans; Gonanes; Macaca; Male; Mammary Neoplasms, Experimental; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progestins; Rats; Receptors, Glucocorticoid; Receptors, Progesterone | 1994 |
Enhancement of the antitumor efficacy of the antiprogestin, onapristone, by combination with the antiestrogen, ICI 164384.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Estradiol; Estrogen Antagonists; Female; Gonanes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Hormone-Dependent; Organ Size; Ovary; Polyunsaturated Alkamides; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Uterus | 1994 |
Potentiation of the antitumor effect of tamoxifen by combination with the antiprogestin onapristone.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Gonanes; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Tamoxifen | 2009 |